AbbVie Inc. announced Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022. Mr. Reents previously served as Vice President, Tax and Treasury from March 2019 to June 2022, as Treasurer from January 2020 to November 2020, and as Vice President, Tax from January 2013 to March 2019. Mr. Reents joined Abbott Laboratories in 2008 and has been with AbbVie since inception in 2013.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
170.5 USD | -0.14% | -0.70% | +10.30% |
06-25 | FDA Again Rejects AbbVie Parkinson's Drug/Pump Combo -- Update | DJ |
06-25 | AbbVie Issues Regulatory Update on New Drug Application for ABBV-951 to Treat Parkinson's Disease | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.30% | 302B | |
+55.22% | 815B | |
+45.31% | 654B | |
-6.82% | 354B | |
+21.59% | 337B | |
+17.75% | 247B | |
+2.09% | 229B | |
+12.93% | 219B | |
+9.75% | 171B | |
-3.68% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Abbvie Inc. Appoints Scott T. Reents as Chief Financial Officer